Moloney Securities Asset Management’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-12,296
Closed -$306K 287
2017
Q3
$306K Buy
+12,296
New +$306K 0.14% 187